Adenosine receptor ligands-recent developments part I. Agonists

CE Muller - Current medicinal chemistry, 2000 - ingentaconnect.com
Developments in the field of adenosine receptor (AR) agonists of the past years are presented
and discussed. Four different AR subtypes, A1, A2A, A2B, and A3, have been cloned from …

Pharmacology and therapeutic applications of A1 adenosine receptor ligands

AK Dhalla, JC Shryock, R Shreeniwas… - Current topics in …, 2003 - ingentaconnect.com
… Studies using these models have for the most part confirmed the known functions of A1
receptors … In summary, both agonists and antagonists for the A1 adenosine receptor have great …

A1 adenosine receptors and their ligands: overview and recent developments

CE Müller - Il farmaco, 2001 - Elsevier
… Potent adenosine receptor (AR) agonists and antagonists with high selectivity for the A 1
AR subtype have been developed during the past decades. However, some of the compounds …

Adenosine receptors and their ligands

KN Klotz - Naunyn-Schmiedeberg's archives of pharmacology, 2000 - Springer
… Table 1 Binding affinity of agonists at human A1, A2A and A3 adenosine receptor subtypes
(Ki-values in nM). For A2B receptors EC50-values (nM) for the agonist-mediated stimulation …

Adenosine receptor agonists

MA Jacobson - Expert Opinion on Therapeutic Patents, 2002 - Taylor & Francis
… the subtypes and is dictated in part by … agonists of A1 adenosine receptors has been
pursued by a number of groups in the effort to identify analogues that may produce less receptor

[HTML][HTML] Recent developments in adenosine receptor ligands and their potential as novel drugs

CE Müller, KA Jacobson - Biochimica et Biophysica Acta (BBA) …, 2011 - Elsevier
… This article is part of a Special Issue entitled: “Adenosine Receptors”. … Several adenosine
receptor agonists and antagonists are currently evaluated in clinical trials. ► AR ligands are …

Emerging adenosine receptor agonists

ZG Gao, KA Jacobson - Expert opinion on emerging drugs, 2007 - Taylor & Francis
… Over a dozen of these selective agonists are now in clinical trials for various conditions, …
except for the endogenous AR agonist adenosine itself. A 1 AR agonists are in clinical trials for …

Adenosine receptor agonists: from basic medicinal chemistry to clinical development

L Yan, JC Burbiel, A Maaß… - Expert opinion on …, 2003 - Taylor & Francis
… A2A adenosine receptor agonists has been discontinued. Major problems include side effects
due to the wide distribution of adenosine receptors; low … part (Figure 1). Figure 2 shows the …

A3 Adenosine Receptor Ligands: History and Perspectives

PG Baraldi, B Cacciari, R Romagnoli… - Medicinal research …, 2000 - Wiley Online Library
agonist for rat A3 adenosine receptors (Fig. 2). IB-MECA 5 is 50-fold selective for A3 vs. …
of the A3 adenosine receptor subtype are, at least in part, elucidated. Series of selective …

[HTML][HTML] Specific ligands for the adenosine receptor family

KA Jacobson - RBI Neurotransmissions, 1996 - everest.bic.nus.edu.sg
… The neuroprotective effect of A 1 receptor activation is, in part, due to counteracting the …
adenosine receptor agonists [7,10,23,24]. The non-selective adenosine receptor agonist N 6 -2-(4…